Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density ; day:18 ; month:8 ; year:2020 ; pages:1-11
European journal of nuclear medicine and molecular imaging ; (18.8.2020), 1-11
- Creator
-
Jochumsen, Mads Ryø
Sörensen, Jens
Pedersen, Bodil Ginnerup
Nyengaard, Jens Randel
Krag, Søren Rasmus Palmelund
Frøkiær, Jørgen
Borre, Michael
Bouchelouche, Kirsten
Tolbod, Lars Poulsen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-020-04998-2
- URN
-
urn:nbn:de:101:1-2020100902332694854651
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jochumsen, Mads Ryø
- Sörensen, Jens
- Pedersen, Bodil Ginnerup
- Nyengaard, Jens Randel
- Krag, Søren Rasmus Palmelund
- Frøkiær, Jørgen
- Borre, Michael
- Bouchelouche, Kirsten
- Tolbod, Lars Poulsen
- SpringerLink (Online service)
Other Objects (12)
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness
Evaluation of protein biomarkers of prostate cancer aggressiveness
Rubidium.
Rubidium
Rubidium
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1
MRI grading for the prediction of prostate cancer aggressiveness
13a Rubidium.
Malignant currents: sodium leak channel NALCN propels prostate cancer aggressiveness
AR-regulated ZIC5 contributes to the aggressiveness of prostate cancer
Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness
Evaluation of protein biomarkers of prostate cancer aggressiveness
Rubidium.
Rubidium
Rubidium
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1
MRI grading for the prediction of prostate cancer aggressiveness
13a Rubidium.
Malignant currents: sodium leak channel NALCN propels prostate cancer aggressiveness
AR-regulated ZIC5 contributes to the aggressiveness of prostate cancer
Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness
Evaluation of protein biomarkers of prostate cancer aggressiveness
Rubidium.
Rubidium
Rubidium
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1
MRI grading for the prediction of prostate cancer aggressiveness
13a Rubidium.
Malignant currents: sodium leak channel NALCN propels prostate cancer aggressiveness
AR-regulated ZIC5 contributes to the aggressiveness of prostate cancer